PharmTech.com, 21 June 2022
ASD-HIPROS Learning Lab
Join our exclusive Learning Lab at CPhI North America
“ASD-HIPROS - A new platform for quick and effective
formulation screening for Amorphous Solid Dispersions by Spray Drying”
Join our expert. In just 20 minutes you will learn:
- Introduction to Hovione’s new formulation screening platform by Spray Drying
- Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development
- Get to know more about Hovione’s extensive expertise in Spray Drying
The number of drug candidates that present low solubility issues has been increasing over the past years. Amorphous Solid Dispersions (ASDs) are an established platform to address bioavailability challenges of poorly soluble drug candidates, offering many of the advantages of more conventional solid oral dosage forms while providing faster dissolution rates and higher drug concentrations. Suboptimal formulations of poorly soluble compounds may result in clinical failures, ultimately increasing the development timeline and associated costs towards identifying a winning candidate. Register now!
Targeted at APIs with poor solubility issues, ASD-HIPROS, Hovione’s Intelligent Proprietary Screening, is a methodology able to evaluate if formulations by Spray Drying are viable candidates towards solving poor bioavailability issues. Equipped with a computational platform coupled with state-of-the-art analytical and spray drying technologies, this platform is able to deliver optimal formulations in record time with minimal consumption of API, maximizing the chance of identifying a successful formulation and accelerating development towards clinical supplies.
Who should attend:
- Investigators and Research fellows
- R&D personnel
- Technical services personnel